Related Experiment Video
Updated: Jun 27, 2025

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters
Guillaume Giraud1,2, Khadija El Achi1, Fabien Zoulim1,2,3
1INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, 69008 Lyon, France.
Insights
Chronic hepatitis B (CHB) infection persists due to hepatitis B virus (HBV) cccDNA. Understanding HBV RNA co-transcriptional regulation offers new strategies to target cccDNA for a complete HBV cure.
Area of Science:
- Virology
- Hepatology
- Molecular Biology
Background:
- Chronic hepatitis B (CHB) is a significant global health issue and a primary cause of liver cancer.
- Current treatments for CHB are insufficient to eradicate the hepatitis B virus (HBV) due to persistent viral cccDNA.
- Developing strategies to eliminate cccDNA is crucial for achieving a functional cure for CHB.
Purpose of the Study:
- This review examines the mechanisms governing HBV RNA co-transcriptional processes.
- It explores how these processes influence viral replication and pathogenesis in CHB.
- The aim is to highlight novel therapeutic targets for CHB.
Main Methods:
- Literature review of studies on HBV cccDNA, transcription, and RNA regulation.
- Analysis of molecular mechanisms controlling HBV RNA co-transcriptional modifications.
- Synthesis of evidence linking co-transcriptional regulation to viral replication and liver disease.
Main Results:
- HBV cccDNA transcription is a critical step for viral replication and RNA variant generation.
- Co-transcriptional regulation of HBV RNAs plays a significant role in CHB pathogenesis.
- Understanding these regulatory mechanisms provides insights into viral persistence.
Conclusions:
- Targeting co-transcriptional regulation of HBV RNAs presents a promising therapeutic avenue.
- Interfering with these processes could lead to the degradation or silencing of cccDNA.
- This approach may offer a pathway to a complete cure for chronic hepatitis B.
Abstract:
Chronic hepatitis B (CHB) virus infection is a major public health burden and the leading cause of hepatocellular carcinoma. Despite the efficacy of current treatments, hepatitis B virus (HBV) cannot be fully eradicated due to the persistence of its minichromosome, or covalently closed circular DNA (cccDNA). The HBV community is investing large human and financial resources to develop new therapeutic strategies that either silence or ideally degrade cccDNA, to cure HBV completely or functionally. cccDNA transcription is considered to be the key step for HBV replication. Transcription not only influences the levels of viral RNA produced, but also directly impacts their quality, generating multiple variants. Growing evidence advocates for the role of the co-transcriptional regulation of HBV RNAs during CHB and viral replication, paving the way for the development of novel therapies targeting these processes. This review focuses on the mechanisms controlling the different co-transcriptional processes that HBV RNAs undergo, and their contribution to both viral replication and HBV-induced liver pathogenesis.
Related Concept Videos
Leaky Scanning
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Transcription Initiation
The promoters and enhancers and their accessory proteins allow tight regulation of...
Types of RNA
RNA Performs Diverse...

